T-cell Therapy Market worth $~14 billion by 2027
The report "T-cell Therapy Market by Modality (Research, Commercialized), Therapy (CAR T-cell, Tumor-Infiltrating Lymphocytes), Indication (Hematologic Malignancies, Solid Tumors) - Global Forecast to 2027", is projected to reach USD ~14 billion by 2027 from USD 6 Billion in 2022, at a CAGR of 18% during the forecast period
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/t-cell-therapy-market-47772841.html
The growth of the T-cell therapy market is driven by focus on developing adoptive therapies and rising investments by private and public agencies. This is further supported by pharmaceutical and biotechnology companies doing extensive R&D for developing cell therapies and recent approvals for new therapies by the FDA. In February 2022, the FDA approved Carvykti (ciltacabtagene autoleucel) for adults with multiple meloma that is not responding to treatment (refractory) or has returned after treatment (relapsed).
The CAR T-cell therapy segment accounted for the largest share of the facial implant market in 2021.
Based on type, the market is segmented into CAR T-cell therapy, T cell receptor (TCR)-based, and tumor infiltrating lymphocytes (TIL)-based. In 2021, the CAR T-cell therapy segment accounted for the largest share of the T-cell therapy market. The key factors driving the growth of this segment are increasing number of clinical trials for CAR-T therapies, and extensive research by pharmaceutical & biotechnology companies and academic institutions for developing T-cell therapeutic products.
North America to command the largest share of the T-cell therapy market in 2021
Based on region, the T-cell therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the T-cell therapy market in 2021. The growth of the North American market is primarily driven by increasing number of regulatory approvals in the US, substantial number of medical centers offering CAR-T cell therapies, and presence of prominent players developing T-cell therapies.
Prominent players in the T-cell therapy market include Novartis AG (Switzerland), Merck KGaA (Germany), Gilead Sciences Inc. (US), TCR2 Therapeutics Inc. (US), Bluebird Bio Inc. (US), Sorrento Therapeutics (US), Fate Therapeutics (US), Pfizer Inc. (US), Amgen (US), and Celgene Corporation (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the CAR T-cell Therapy Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
